Tailoring antineoplastic therapy - pharmacogenomics opening the door

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1277, 2001-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tailoring tacrolimus therapy: the influence of pharmacokinetics and pharmacogenomics

By  

Inpharma, Vol. 1, Iss. 1398, 2003-01 ,pp. : 13-15

Adis International

Access to resources Recommend Favorite

Pharmacogenetics: A Tool for Individualising Antineoplastic Therapy

By Innocenti F.  

Clinical Pharmacokinetics, Vol. 39, Iss. 5, 2000-11 ,pp. : 315-325

Adis International

Access to resources Recommend Favorite

Pharmacogenomics for tailoring cardiovascular and anticancer drugs: from genotyping to whole-genome sequencing

By Katsios Christos S   Ziogas Dimosthenis E   Roukos Dimitrios H  

Pharmacogenomics, Vol. 12, Iss. 8, 2011-08 ,pp. : 1081-1085

Future Medicine

Access to resources Recommend Favorite

HIV Pharmacogenomics: Closer to Personalized Therapy?

By Payne D.A.   Bryant B.J.  

American Journal of PharmacoGenomics, Vol. 4, Iss. 3, 2004-01 ,pp. : 141-150

Adis International

Access to resources Recommend Favorite

Personalized therapy and pharmacogenomics: future perspective

By Siest Géérard   Marteau Jean-Brice   Visvikis-Siest Sophie  

Pharmacogenomics, Vol. 10, Iss. 6, 2009-06 ,pp. : 927-930

Future Medicine

Access to resources Recommend Favorite